“QANDLI DIABETDA INDIVIDUALIZATSIYALANGAN DAVOLASH: INSULIN TERAPIYASI VA ZAMONAVIY GLP-1 AGONISTLARI O‘RNI”

Article Sidebar

PDF (Русский)
Issue: Vol. 5 No. 3 : Central Asian Journal of Education and Innovation
Section: Articles
Published:

Main Article Content

Toshkent Davlat Tibbiyot Universiteti 1 son tibbiy radiologiya kafedrasi assistenti
info@in-academy.uz
Toshkent Davlat Tibbiyot Universiteti 2-davolash fakulteti 2-bosqich talabasi
info@in-academy.uz

Abstract:

Ushbu maqolada qandli diabetni davolashning zamonaviy usullari, xususan insulin terapiyasi va GLP-1 retseptor agonistlarining qo‘llanilishi tahlil qilinadi. Qandli diabet dunyo bo‘yicha keng tarqalgan metabolik kasalliklardan biri bo‘lib, qondagi glukoza miqdorini nazorat qilish va asoratlarning oldini olish uchun samarali davolash strategiyalarini talab qiladi.

Article Details

How to Cite:

Musulmonov, S., & Atovullayeva, M. . (2026). “QANDLI DIABETDA INDIVIDUALIZATSIYALANGAN DAVOLASH: INSULIN TERAPIYASI VA ZAMONAVIY GLP-1 AGONISTLARI O‘RNI”. Central Asian Journal of Education and Innovation, 5(3), 90–97. Retrieved from https://in-academy.uz/index.php/cajei/article/view/77049

References:

American Diabetes Association. Standards of Medical Care in Diabetes – 2024. Diabetes Care, 2024.

World Health Organization. Diabetes. Geneva:

WHO, 2023.

DeFronzo R.A., Ferrannini E., Zimmet P., Alberti G. International Textbook of Diabetes Mellitus. Wiley-Blackwell, 2015.

Davies M.J., et al. Management of hyperglycemia in type 2 diabetes. Diabetes Care, 2022.

Holst J.J., Vilsbøll T. The role of GLP-1 in the treatment of type 2 diabetes. Nature Reviews Endocrinology, 2018.

Kalra S., Gupta Y. Combination therapy with insulin and GLP-1 receptor agonists in diabetes management. Diabetes Therapy, 2020